Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Post-traumatic Stress Symptoms 1Ovarian Neoplasms 1Neoplasms 1Frailty 1Endometrial Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Specimen Handling 629pembrolizumab 559Magnetic Resonance Spectroscopy 539Carboplatin 423Cyclophosphamide 371Cisplatin 371Biopsy 357Paclitaxel 304Nivolumab 301Gemcitabine 299Radiotherapy 270Bevacizumab 238Dexamethasone 207fludarabine 205Docetaxel 189durvalumab 178atezolizumab 176Oxaliplatin 172Fluorouracil 167venetoclax 164Rituximab 164Pemetrexed 162Radiation 159Doxorubicin 159Capecitabine 158Radiosurgery 147Etoposide 137Ipilimumab 134Leucovorin 133Lenalidomide 130

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Psychosocial Intervention × 90 days × Clear all
NCT07582666 2026-05-13

CAERES

UniDistance Suisse

Phase NA Completed
32 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT07160933 2026-03-31

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

Massachusetts General Hospital

Phase NA Not yet recruiting
80 enrolled

Post-traumatic Stress Symptoms

NCT04789694 2026-03-19

PHOCUS

Charles University, Czech Republic

Phase 3 Recruiting
64 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡